Advanced Technology-based Rehabilitation Post-stroke Gait Re-learning
NCT: NCT06497309 · COMPLETED
Brief Summary
High-tech therapy, an innovative field of neurorehabilitation, has expanded rapidly in recent years. Advances in technology have enabled the use of devices that can assist with movement development from simple movements to more complex tasks. This research investigates the effectiveness of rehabilitation programmes that complement robot-assisted therapy to help people relearn to walk in post-stroke rehabilitation. This would be measured in two variations, with the patient (in addition to a complex rehabilitation programme of conventional physiotherapy, occupational therapy, hydrotherapy, etc.) receiving either treadmill or no treadmill treatment. In both cases, the therapies will be carried out with advanced technology-based equipment (both treatments are part of the daily routine of the Institute's treatments, and the equipment will be used according to the instructions in the user manual), the C-Mill interactive robot-assisted device will be used for treadmill therapy, and the Andago robot-assisted device for non- treadmill therapy. There is no sharp distinction between the two systems. The inclusion and exclusion criteria are set so patients' conditions meet the indications for both devices, and patients eligible for treatment with one device are included in the other. In our study, 80 patients will be selected.
Frequently Asked Questions
What is Advanced Technology-based Rehabilitation Post-stroke Gait Re-learning?
Advanced Technology-based Rehabilitation Post-stroke Gait Re-learning is a clinical trial registered under NCT06497309. Current status: COMPLETED.
What is the status of NCT06497309?
The current status of NCT06497309 (Advanced Technology-based Rehabilitation Post-stroke Gait Re-learning) is: COMPLETED.
When did Advanced Technology-based Rehabilitation Post-stroke Gait Re-learning start?
Advanced Technology-based Rehabilitation Post-stroke Gait Re-learning started on 2024-01-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.